JourneyLite is happy to announce that we are now offering compounded sublingual semaglutide and tirzepatide drops for weight loss! The landscape of weight management treatments has seen significant advancements in recent years, particularly with the introduction of GLP-1 receptor agonists like semaglutide and dual GIP/GLP-1 receptor agonists like tirzepatide. JourneyLite has been treating patients with these medications for several years and some patients are seeing astounding results. Traditionally offered at JourneyLite in injectable forms, these medications have demonstrated remarkable efficacy promoting weight loss. However, compounded sublingual formulations of these drugs, such as semaglutide and tirzepatide drops, are emerging as a potential alternative to injections, offering convenience and improved patient compliance. We are happy to announce the availability of these drops for weight loss at JourneyLite!
Understanding Semaglutide and Tirzepatide
Semaglutide is a GLP-1 receptor agonist that mimics the effects of the naturally occurring hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. This results in improved glycemic control and significant weight loss.
Tirzepatide, on the other hand, is a dual GIP and GLP-1 receptor agonist that provides similar benefits but with additional metabolic advantages due to its action on GIP receptors. Clinical trials have shown that tirzepatide can lead to superior weight loss and glycemic control compared to GLP-1 agonists alone.
The Emergence of Sublingual Drops
The conventional administration of semaglutide and tirzepatide has been through subcutaneous injection, which some patients find inconvenient or uncomfortable. As a result, compounded sublingual formulations have gained attention as a non-invasive alternative. These formulations involve placing liquid drops under the tongue, allowing the active ingredients to be absorbed directly into the bloodstream through the mucous membranes.
Potential Benefits of Sublingual Administration
- Enhanced Patient Compliance – Many individuals are hesitant to use injectable medications due to needle aversion. Sublingual drops provide a painless alternative that may improve adherence to treatment regimens.
- Faster Absorption – The sublingual route bypasses the digestive system, potentially leading to quicker and more efficient absorption compared to oral formulations that undergo first-pass metabolism in the liver.
- Reduced Gastrointestinal Side Effects – Traditional semaglutide and tirzepatide injections often cause nausea, vomiting, and gastrointestinal discomfort. Sublingual administration may mitigate some of these side effects by altering how the medication is absorbed.
- Customizable Dosing – Compounded formulations allow for personalized dosing, which may be beneficial for patients requiring dose adjustments based on their response to therapy.
Challenges and Considerations
Despite the promising potential of sublingual semaglutide and tirzepatide, there are some challenges and concerns that need to be addressed:
- Efficacy and Bioavailability – Injectable formulations have established pharmacokinetic profiles, but the bioavailability of sublingual versions is not yet well-documented. Further clinical studies are necessary to confirm their effectiveness.
- Regulatory and Safety Concerns – Compounded medications are not FDA-approved and may vary in quality and consistency between different compounding pharmacies. JourneyLite uses a trusted US-based partner for all compounding needs, which is PCAB-accredited in both sterile and non-sterile pharmacy compounding—a distinction held by fewer than 1% of pharmacies
- Cost and Accessibility – Insurance coverage may not extend to compounded formulations, making them potentially more expensive than FDA-approved injectable versions. Many patients have no coverage for the brand-name medications either, in which case the compounded versions can be significantly cheaper than self-paying for Wegovy or Zepbound.
Conclusion
JourneyLite is excited to offer compounded sublingual semaglutide and tirzepatide drops, representing an exciting innovation in weight management. By offering a needle-free alternative with potential advantages in compliance and absorption, they have the potential to transform the way these medications are administered. If you’re interested in discussing these options with an experienced medical provider, request a consultation below! Or if you just have questions, feel free to use our contact us form.
